Search
Toggle theme
Menu
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration | NobleBlocks
Back
Home
Publications
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration
Public
More options
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration
N
Shared by
NobleBlocks
on Sep 1, 2025 • 12:00 AM UTC
Authors:
Gabriela Grimaldi
,
Aude Ambresin
,
Isabel B. Pfister
+20 more
Download PDF
Share
Summary
Sum
PDF
Figures
Figs
Discrepancies
Disc
EDDII
Article
Art
Finding related papers...
Discussions
(0)
Add Comment
No comments yet
Be the first to share your thoughts!
